Life Edit Therapeutics

ElevateBio is a technology-driven company built to power the development of transformative cell and gene therapies today and for many decades to come. The company has assembled industry-leading talent, built state-of-the-art facilities, and integrated diverse technology platforms, including gene editing, induced pluripotent stem cells (iPSCs), and protein, vector, and cellular engineering, necessary to drive innovation and commercialization of cellular and genetic medicines. In addition, ElevateBio BaseCamp is a purpose-built, technology-enabled manufacturing platform offering process innovation, process sciences, and current Good Manufacturing Practice (cGMP) manufacturing capabilities for viral vectors, RNA, and cell therapy production. Through BaseCamp, its expanding footprint, and its next-generation enabling technologies, ElevateBio is rapidly growing its collaborations with industry partners while also selectively developing its own portfolio of cellular and genetic medicines. 

ElevateBio's team of scientists, drug developers, and company builders are redefining what it means to be a technology company in the world of drug development, blurring the line between technology and healthcare.

AlloVir

Samsara BioCapital

Surveyor Capital

Vertex Ventures

Invus

ITOCHU Corporation

Redmile Group

EDBI

Emerson Collective

F2 Ventures

Fidelity Management and Research Company

Woodline Partners

Matrix Capital Management

Novo Nordisk

Fidelity

ElevateBio

Exciting news!  Life Edit Therapeutics Chief Scientific Officer, Tedd Elich, was recently highlighted in BioPharm International in the feature, "Milestone Approval to Steady Stream, Gene Editing Revs Up." Gain valuable insights into the future of gene editing, technology advancements, and more. Access the full article in the comments below.

Our Life Edit gene editing business offers diverse tools for unlimited gene editing. This platform boasts the ability to make "any edit anywhere" - from small deletions and insertions to rewriting the DNA sequence – and delivers versatility and flexibility. 

Learn more about partnering with us at https://lnkd.in/gMf9yFkv

#ElevateBio #InnovateAtElevate #GeneticMedicine

No matter where you are with your development journey, our LentiPeak™ platform can help you reach your next milestone faster.

Our proprietary lentiviral vector (LVV) platform is suspension-based and scalable to meet your needs, offering streamlined tech transfers, control strategies for risk mitigation and proven performance with CAR and TCR constructs at multiple production scales.

Take the first step towards elevating our future together: https://lnkd.in/ed8fRD-F.

#GeneManufacturing #ElevateBio

Frank Bugg, our Global Head of BaseCamp Operations will discuss BaseCamp's capabilities in supporting partnerships across research, discovery, analytical development, and more as part of the Outsourced Pharma Capacity Update series on February 15 at 10 am EST. 

Register at https://lnkd.in/eEMjUqyS. 

#ElevateBio #Biotech 

We guide our partners through their journey from concept to commercialization, or at any stage in between. BaseCamp, our cGMP manufacturing facility, is equipped for the full product lifecycle; we have expertise in developing and scaling processes for cell therapies and viral vectors, and we offer analytical and enabling services, too. 
Our proprietary lentiviral vector platform–LentiPeak™–can be fully customized to fit partners’ needs. 

Learn more about the benefits of a strategic relationship with ElevateBio: https://lnkd.in/evp85Xpk.

#BaseCamp #CellTherapy #GeneTherapy


Viewport Meta

IPhone / Mobile Compatible

Domain Not Resolving

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

Google Font API

DNSSEC

WordPress

Font Awesome

CEO & Chairman

David L. Hallal

General Counsel

Jacob Abrams

Chief Business Officer

Kareem Reda

Chief Scientific Officer of Regenerative Medicine

Melissa Carpenter

Chief Technology Officer, ElevateBio BaseCamp

Michael Paglia

Vikas Sinha

Senior Vice President, Supply Chain Strategic Operations

Andreas Kouri

Vice President Early Development

Andrew Denker

Senior Vice President Finance

Bhakti Bhargava

VP, Head of Program Management

Brian Majors

Mario G. Giuliani

Karan Takhar

Deep Nishar

Khalil Barrage

Ansbert Gadicke

Morana Jovan-Embiricos

Navneet Govil

David Hallal

CEO, Chair, & Co-Founder

Mitchell Finer

Chief Scientific Officer

Chief Financial Officer

CSO, Regenerative Medicine

Agustin Melian

Chief Development Officer

Senior Vice President, CMC Operations

Jill Mooney

SVP of Research and Development

AlloVir focuses on  the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.

New England Companies With Less Than $500M in Revenue (Top 10K)

Massachusetts Companies With Fewer Than 1000 Employees (Top 10K)

United States Investors (Top 10K)

Massachusetts Companies With Less Than $1B in Revenue (Top 10K)

ElevateBio is an operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines.

The company creates a portfolio through partnerships with the world's innovative scientists and inventors as well as it created a centralized facility that integrates all the elements that translate cell and gene therapy R&D into commercially viable therapies quickly and efficiently, enabling patients to get medical products to treat severe diseases.

Vikas Sinha, Mitchell Finer, and David Hallal co-founded ElevateBio in Cambridge, Massachusetts in 2017.

Series D - ElevateBio

Series C - ElevateBio

Series B - ElevateBio

UBS Oncology Impact Fund

Series A - ElevateBio

Computer and Software Services and Scientific Services

Waltham

Massachusetts

United States

North America

Gene Therapy Market to Grow by USD 6.74 Billion from 2024-2028, as Rise in Special Drug Designations Drives Demand with AI-Powered Market Evolution - Technavio

These US Universities Graduate The Highest Number Of Funded Founders

Xcell Biosciences Announces Collaboration with ElevateBio to Advance Technology Development for Cell and Gene Therapies

Despite one of biotech's biggest fundraisings of the year, ElevateBio cuts 13% of staff

For $100M-Plus Rounds, It’s Unclear What’s Normal

Pitt presents vision for ElevateBio-operated manufacturing project

North American Startup Funding Fell Across All Stages In Q2

Mid-Year Report: Who Could Still Go Public In 2023?

University of Pittsburgh committee OKs ElevateBio lease

Philippines

Asia

Palestinian Territory

Pakistan

HTML5

Google Analytics

Google Drive

Modernizr

Google Fonts

Wordpress

HubSpot Forms

Adobe Fonts

GoDaddy Premium DNS

Verge Genomics is a biotechnology company focused on developing therapeutics for neurodegenerative diseases using machine learning and genomics.

Verge Genomics

Locanabio is a biotechnology company specializing in developing RNA-targeted gene therapies for neurodegenerative and neuromuscular diseases.

Locanabio

Voyager is a biotechnology company that focuses on developing gene therapies for severe neurological diseases.

Voyager

Xcell Biosciences is a platform technology company focused on cell and gene therapy applications.

Xcell Biosciences, Inc. (Xcellbio)

ElevateBio is a technology-driven genetic medicines company, accelerating access to cutting-edge technologies, end-to-end manufacturing capabilities, and expertise to advance the cell and gene therapy industry. The company's integrated ecosystem of technologies and capabilities enables the discovery, development, manufacturing, and commercialization of a broad spectrum of cell and gene therapies and regenerative medicines.

Director, Quality Systems

Director, QA

Associate Director QA

Sr. Manager - QA

QA Validation Manager

QC Manager

QC Senior Analyst

Quality Control Analyst II

QC Analyst II

QC Analyst I

Daniel Hage

Director, R&D Program Management

Director, Business Development & Alliance Management

Director of Program Management

Associate Director, Research & Development

Principal Scientist

Staff Scientist

Project Scientist/Research Scientist

Post-doctoral Fellow

Charito Buensuceso

Associate Director, ERP Architect

Engagement Manager

Principal Consultant

SAP Consultant

Associate Director, ERP Architect at ElevateBio

Shantharam Ramaswamy

Associate Director, QA Process Validation

Senior Manager, QA Process Validation

Senior Manager, Quality Assurance Gene Therapy

Manager, Quality Assurance Validation

Manager, Quality Operations

Manager Quality Control

Associate Manager, Quality Control

Senior Quality Control Associate

Quality Control Associate

Quality Control Assistant

Quality Control Analyst

Nora Phillips

Associate Director, Stem Cell Research & Development

Anthony Romer

Associate Director, CMC Commercial Operations

Associate Director, CMC Operations & Program Management

Senior Manager, CMC Operations & Program Management

Client Program Manager

Senior Specialist (BRAMMER BIO)

Stability and Reference Standard Lead (BRAMMER BIO)

Microbiology Analyst

Associate Director, CMC Commercial Operations at ElevateBio

Samantha Hulbert

Director - Intellectual Property Legal Counsel

Patent Attorney

Patent Agent

Graduate Publications Intern

Teaching Assistant/Research Assistant

Patent Attorney at ElevateBio

Anne Fleckenstein

Associate Director, IT Infrastructure and Operations

IT Site Manager / Cloud Infrastructure Engineer / Network Engineer

IT Site Manager / Network Engineer

IT Site Manager / Network Administrator

Database Developer

Associate Director, IT Infrastructure and Operations at ElevateBio

Michael Dennis

Director, Cloud & Network Architecture

Senior Solutions Architect

Critical Infrastructure Lead

SME / SDM Compute, Virtualization, Storage - VMWare

Compute Infrastructure Engineer

DevOps / Senior Lead Engineer

Director, Cloud & Network Architecture at ElevateBio

Konstantine T.

Associate Director, Quality Control, ElevateBio

Associate Director Product Development

Senior Pharmaceutical Scientist

Senior Scientist

Scientist

Associate Director, Quality Control

Alisha Weight

Director, Quality Control

Associate Director, Quality Control (Cell & Gene Therapy Analytics)

Director of Quality and Regulatory

Process and Analytical Validation Scientist

Quality Control Validation Manager

Quality Control Validation Team Lead

Christine Corl

news impact assignment basic	general	Mar 4, 2024 2:15 AM	60391b20
public peers	general
news daily refresh	general	Sep 1, 2024 6:10 PM	e9153dcf
news processing daily refresh	general	Sep 2, 2024 1:59 PM	37f4fd43
news impact assignment daily	general	Sep 2, 2024 11:08 PM	b65c8cf7
news processing basic	general	Mar 4, 2024 2:15 AM	4b7cff0e
company summary	general	Aug 30, 2024 5:17 PM	9195dd22
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	5c863f26
crunchbase profile	general	Nov 22, 2024 7:46 AM	3914257f
li profile	general	Mar 4, 2024 2:15 AM	bd4f02d3
translate crunchbase fundingrounds	general	Nov 22, 2024 8:02 AM	8f07bb52
peers	general
news basic	general	Mar 4, 2024 2:15 AM	cf0f9a5b
bundesanzeiger	filings
financials download nd	financials
private financials	financials

BIO:ELEVATE

ElevateBio